UK Scraps Pneumonia Vaccines Because They 'Don't Work'
June 20, 2011
Spread the Word to
Friends And Family
By Sharing this Article.
The United States requires infants to receive 26 vaccines (the most in the world) yet more than 6 U.S. infants die per every 1,000 live births. In contrast, Sweden and Japan administer 12 vaccines to infants, the least amount, and report less than 3 deaths per 1,000 live births.
The study also found evidence that some infant deaths attributed to sudden infant death syndrome (SIDS) may actually be vaccine-related.
According to a recent press release:
The current study by Miller and Goldman, "Infant Mortality Rates Regressed Against Number of Vaccine Doses Routinely Given: Is There a Biochemical or Synergistic Toxicity?" found a high statistically significant correlation between increasing number of vaccine doses and increasing infant mortality rates.This raises an important question: Would fewer vaccines administered to infants reduce the number of infant deaths?
Other study findings:
The United States spends more per capita on healthcare than any other country; yet 33 nations have better infant mortality rates. Some infant deaths attributed to sudden infant death syndrome (SIDS) may be due to over-vaccination.
Progress on reducing infant deaths should include monitoring immunization schedules and official causes of death (to determine if vaccine-related infant deaths are being reclassified). Infant mortality rates will remain high in developing nations that cannot provide clean water, proper nutrition, improved sanitation, and better access to health care.
At times it is later revealed that vaccines are not even effective. For instance, pneumonia vaccinations for people over 65 are soon to be halted by the UK government, on the grounds that the injections do not save lives.
Millions of people were injected with the vaccine, which was supposed to offer ten-year protection against an infection that causes pneumonia. But independent expert government advisors say the program has had 'no discernible impact' on rates of pneumococcal disease. According to the Daily Mail:
"... [T]he protection provided by the vaccine is poor and not long-lasting in older people."